{"id":"https://openalex.org/W2083665563","doi":"https://doi.org/10.1046/j.1365-2036.1999.00003.x-i2","title":"Review article: the therapeutic potential of 5\u2010HT3receptor antagonists in the treatment of irritable bowel syndrome","display_name":"Review article: the therapeutic potential of 5\u2010HT3receptor antagonists in the treatment of irritable bowel syndrome","publication_year":1999,"publication_date":"1999-05-01","ids":{"openalex":"https://openalex.org/W2083665563","doi":"https://doi.org/10.1046/j.1365-2036.1999.00003.x-i2","mag":"2083665563","pmid":"https://pubmed.ncbi.nlm.nih.gov/10429738"},"language":"en","primary_location":{"id":"doi:10.1046/j.1365-2036.1999.00003.x-i2","doi":"https://doi.org/10.1046/j.1365-2036.1999.00003.x-i2","is_oa":true,"landing_page_url":"https://doi.org/10.1046/j.1365-2036.1999.00003.x-i2","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2036.1999.00003.x-i2","source":{"id":"https://openalex.org/S158079644","display_name":"Alimentary Pharmacology & Therapeutics","issn_l":"0269-2813","issn":["0269-2813","1365-2036"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alimentary Pharmacology & Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2036.1999.00003.x-i2","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110434114","display_name":"Patrick P.A. Humphrey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I241749","display_name":"University of Cambridge","ror":"https://ror.org/013meh722","country_code":"GB","type":"education","lineage":["https://openalex.org/I241749"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"P.P.A. Humphrey","raw_affiliation_strings":["Glaxo Institute of Applied Pharmacology, Department of Pharmacology, University of Cambridge, Cambridge, Uk,","Glaxo Institute of Applied Pharmacology, Department of Pharmacology, University of Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Glaxo Institute of Applied Pharmacology, Department of Pharmacology, University of Cambridge, Cambridge, Uk,","institution_ids":["https://openalex.org/I241749"]},{"raw_affiliation_string":"Glaxo Institute of Applied Pharmacology, Department of Pharmacology, University of Cambridge, UK","institution_ids":["https://openalex.org/I241749"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113950006","display_name":"C. Bountra","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. Bountra","raw_affiliation_strings":["Glaxo Wellcome Research and Development Ltd, Disease Sciences Division, Stevenage, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Glaxo Wellcome Research and Development Ltd, Disease Sciences Division, Stevenage, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110136019","display_name":"Nick M. Clayton","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N. Clayton","raw_affiliation_strings":["Glaxo Wellcome Research and Development Ltd, Disease Sciences Division, Stevenage, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Glaxo Wellcome Research and Development Ltd, Disease Sciences Division, Stevenage, UK","institution_ids":[]}]},{"author_position":"last","author":{"id":null,"display_name":"K. Kozlowski","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. Kozlowski","raw_affiliation_strings":["Glaxo Wellcome Research and Development Ltd, Disease Sciences Division, Stevenage, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Glaxo Wellcome Research and Development Ltd, Disease Sciences Division, Stevenage, UK","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5110434114"],"corresponding_institution_ids":["https://openalex.org/I241749"],"apc_list":{"value":5250,"currency":"USD","value_usd":5250},"apc_paid":null,"fwci":7.2349,"has_fulltext":true,"cited_by_count":94,"citation_normalized_percentile":{"value":0.9745706,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"13","issue":"s2","first_page":"31","last_page":"38"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10365","display_name":"Gastrointestinal motility and disorders","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10365","display_name":"Gastrointestinal motility and disorders","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13289","display_name":"Infant Health and Development","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3611","display_name":"Pharmacy"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/5-ht3-receptor-antagonists","display_name":"5-HT3 receptor antagonists","score":0.9520000219345093},{"id":"https://openalex.org/keywords/irritable-bowel-syndrome","display_name":"irritable bowel syndrome","score":0.9900000095367432},{"id":"https://openalex.org/keywords/alosetron","display_name":"alosetron","score":0.9089999794960022},{"id":"https://openalex.org/keywords/diarrhoea-predominant-ibs","display_name":"diarrhoea-predominant IBS","score":0.949999988079071},{"id":"https://openalex.org/keywords/visceral-nociception","display_name":"visceral nociception","score":0.972000002861023},{"id":"https://openalex.org/keywords/intestinal-motility","display_name":"intestinal motility","score":0.7300000190734863},{"id":"https://openalex.org/keywords/abdominal-pain","display_name":"abdominal pain","score":0.8330000042915344},{"id":"https://openalex.org/keywords/serotonin","display_name":"serotonin","score":0.7570000290870667}],"concepts":[{"id":"https://openalex.org/C2778271842","wikidata":"https://www.wikidata.org/wiki/Q838966","display_name":"Irritable bowel syndrome","level":2,"score":0.8209255337715149},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.755073070526123},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.6813108921051025},{"id":"https://openalex.org/C53910766","wikidata":"https://www.wikidata.org/wiki/Q238516","display_name":"5-HT receptor","level":4,"score":0.6161561608314514},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.6041049361228943},{"id":"https://openalex.org/C2778122271","wikidata":"https://www.wikidata.org/wiki/Q410943","display_name":"Receptor antagonist","level":4,"score":0.5618283748626709},{"id":"https://openalex.org/C15490471","wikidata":"https://www.wikidata.org/wiki/Q2734305","display_name":"Nociception","level":3,"score":0.5256304144859314},{"id":"https://openalex.org/C24998067","wikidata":"https://www.wikidata.org/wiki/Q4114622","display_name":"Stimulation","level":2,"score":0.5233929753303528},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.482099324464798},{"id":"https://openalex.org/C2780955771","wikidata":"https://www.wikidata.org/wiki/Q183425","display_name":"Abdominal pain","level":2,"score":0.4172130525112152},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38388827443122864},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.372108519077301},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.35609233379364014}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002243","descriptor_name":"Carbolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002243","descriptor_name":"Carbolines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003109","descriptor_name":"Colonic Diseases, Functional","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007422","descriptor_name":"Intestines","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D011985","descriptor_name":"Receptors, Serotonin","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D012702","descriptor_name":"Serotonin Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D012702","descriptor_name":"Serotonin Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1046/j.1365-2036.1999.00003.x-i2","doi":"https://doi.org/10.1046/j.1365-2036.1999.00003.x-i2","is_oa":true,"landing_page_url":"https://doi.org/10.1046/j.1365-2036.1999.00003.x-i2","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2036.1999.00003.x-i2","source":{"id":"https://openalex.org/S158079644","display_name":"Alimentary Pharmacology & Therapeutics","issn_l":"0269-2813","issn":["0269-2813","1365-2036"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alimentary Pharmacology & Therapeutics","raw_type":"journal-article"},{"id":"pmid:10429738","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10429738","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alimentary pharmacology & therapeutics","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1046/j.1365-2036.1999.00003.x-i2","doi":"https://doi.org/10.1046/j.1365-2036.1999.00003.x-i2","is_oa":true,"landing_page_url":"https://doi.org/10.1046/j.1365-2036.1999.00003.x-i2","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2036.1999.00003.x-i2","source":{"id":"https://openalex.org/S158079644","display_name":"Alimentary Pharmacology & Therapeutics","issn_l":"0269-2813","issn":["0269-2813","1365-2036"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alimentary Pharmacology & Therapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.7599999904632568,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2083665563.pdf","grobid_xml":"https://content.openalex.org/works/W2083665563.grobid-xml"},"referenced_works_count":62,"referenced_works":["https://openalex.org/W88073431","https://openalex.org/W264128994","https://openalex.org/W1772950163","https://openalex.org/W1895455191","https://openalex.org/W1913503189","https://openalex.org/W1975662189","https://openalex.org/W1983433110","https://openalex.org/W1987084628","https://openalex.org/W1988118458","https://openalex.org/W1989160846","https://openalex.org/W1992937821","https://openalex.org/W1995909187","https://openalex.org/W1996852467","https://openalex.org/W1996898160","https://openalex.org/W1998457950","https://openalex.org/W2001861109","https://openalex.org/W2005395166","https://openalex.org/W2007066940","https://openalex.org/W2007269921","https://openalex.org/W2009805742","https://openalex.org/W2009821818","https://openalex.org/W2011663436","https://openalex.org/W2012141492","https://openalex.org/W2022200447","https://openalex.org/W2028028344","https://openalex.org/W2028855732","https://openalex.org/W2033192117","https://openalex.org/W2037284544","https://openalex.org/W2038016377","https://openalex.org/W2039680393","https://openalex.org/W2042142736","https://openalex.org/W2048401140","https://openalex.org/W2055776948","https://openalex.org/W2056303196","https://openalex.org/W2058791686","https://openalex.org/W2059008876","https://openalex.org/W2059324071","https://openalex.org/W2064644850","https://openalex.org/W2067438641","https://openalex.org/W2073056198","https://openalex.org/W2076438268","https://openalex.org/W2076604579","https://openalex.org/W2081439775","https://openalex.org/W2082812826","https://openalex.org/W2097055087","https://openalex.org/W2102650760","https://openalex.org/W2107237727","https://openalex.org/W2114938591","https://openalex.org/W2137056703","https://openalex.org/W2153853866","https://openalex.org/W2158025174","https://openalex.org/W2248001441","https://openalex.org/W2274287867","https://openalex.org/W2328269561","https://openalex.org/W2333050500","https://openalex.org/W2399557677","https://openalex.org/W2400916537","https://openalex.org/W2418229780","https://openalex.org/W2428838675","https://openalex.org/W2772887788","https://openalex.org/W3027955914","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W1983350548","https://openalex.org/W3188280133","https://openalex.org/W2071956277","https://openalex.org/W4376504906","https://openalex.org/W1992657918","https://openalex.org/W2128085120","https://openalex.org/W1975600390","https://openalex.org/W3029224518","https://openalex.org/W2657509782","https://openalex.org/W2095126066"],"abstract_inverted_index":{"There":[0],"is":[1,68,100,109,149],"evidence":[2],"from":[3],"studies,":[4],"in":[5,17,25,56,82,152],"both":[6],"animals":[7],"and":[8,43,62,91,144],"humans,":[9],"that":[10,35,44,142],"5-HT3":[11,36,79,105,124,146],"receptor":[12,80,106,147],"blockade":[13,122,148],"has":[14],"potential":[15],"value":[16,151],"the":[18,76,127,139,153],"treatment":[19,154],"of":[20,78,123,150,155],"irritable":[21],"bowel":[22,30],"syndrome,":[23],"particularly":[24],"those":[26],"patients":[27,83],"with":[28,84,112],"diarrhoea-predominant":[29],"habits.":[31],"New":[32],"findings":[33],"suggest":[34],"receptors":[37,125],"exist":[38],"on":[39],"gut":[40,86],"afferent":[41],"neurones":[42],"their":[45],"activation":[46],"by":[47],"locally":[48],"released":[49],"5-HT":[50],"leads":[51],"to":[52,58,96,119,137],"visceral":[53],"nociceptive":[54,93],"stimulation,":[55],"addition":[57],"increased":[59,85],"neuronally-mediated":[60],"motor":[61],"secretory":[63],"activity.":[64],"If":[65],"this":[66],"concept":[67],"validated,":[69],"it":[70,130],"will":[71],"provide":[72,120],"a":[73,101,113],"rationale":[74],"for":[75],"use":[77],"antagonists":[81],"motility,":[87],"reduced":[88],"fluid":[89],"absorption":[90],"low":[92],"thresholds":[94],"leading":[95],"abdominal":[97],"pain.":[98],"Alosetron":[99],"highly":[102],"selective,":[103],"potent":[104],"antagonist":[107],"which":[108],"well":[110],"absorbed":[111],"long":[114],"pharmacodynamic":[115],"half-life.":[116],"Its":[117],"ability":[118],"long-lasting":[121],"throughout":[126],"body":[128],"make":[129],"an":[131],"ideal":[132],"candidate":[133],"within":[134],"its":[135],"class":[136],"evaluate":[138],"clinical":[140],"hypothesis":[141],"sustained":[143],"ubiquitous":[145],"IBS.":[156]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}